Screening for alcohol use disorder among individuals with comorbid psychiatric disorders: Diagnostic accuracy in a sample of young Swiss men.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
07 2020
Historique:
received: 17 09 2019
revised: 27 01 2020
accepted: 11 02 2020
pubmed: 7 3 2020
medline: 15 5 2021
entrez: 6 3 2020
Statut: ppublish

Résumé

Alcohol use disorder (AUD) is frequently comorbid with other psychiatric disorders. However, few studies investigated the psychometric properties of AUD screening tools in presence of co-occurring disorders. This study examined the diagnostic accuracy of a short AUD screening tool among young adults, in the presence of high vs. low or moderate symptomatology of other common psychiatric disorders. Data were collected among young Swiss men (n = 233) between 2016 and 2018. Measures included a diagnostic interview for AUD and screening tools for AUD and other psychiatric disorders (attention deficit hyperactivity disorder, antisocial personality disorder, bipolar disorder, borderline personality disorder, major depressive disorder, and social anxiety disorder). We computed receiver operating characteristic curves to test whether the AUD screening tool was an accurate indicator of AUD for groups with high vs. low or moderate symptomatology of each psychiatric disorder. The results showed that the optimal cut-off score was ≥3 (the original cut-off of the scale) for participants with a low or moderate symptomatology and ≥4 for participants with a high symptomatology. Our findings highlighted the urgent need for an integrated approach to screening. Psychiatric comorbidities should be included in the screen for AUD to obtain accurate results.

Identifiants

pubmed: 32135396
pii: S0306-4603(19)31114-1
doi: 10.1016/j.addbeh.2020.106354
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106354

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Stéphanie Baggio (S)

Division of Prison Health, Geneva University Hospitals and University of Geneva, Chemin du Petit Bel Air 2, 1226 Thônex, Switzerland; Department of Forensic Psychiatry, Institute of Forensic Medicine, University of Bern, Falkenplatz 16, 3012 Bern, Switzerland; Office of Corrections, Zurich, Switzerland. Electronic address: stephanie.baggio@hcuge.ch.

Sophie Baudat (S)

Division of Prison Health, Geneva University Hospitals and University of Geneva, Chemin du Petit Bel Air 2, 1226 Thônex, Switzerland; Family and Development Research Center, Institute of Psychology, University of Lausanne, Geopolis Building, 1015 Lausanne, Switzerland.

Jean-Bernard Daeppen (JB)

Addiction Medicine, Department of Psychiatry, Lausanne University Hospital, Rue du Bugnon 23, 1011 Lausanne, Switzerland.

Gerhard Gmel (G)

Addiction Medicine, Department of Psychiatry, Lausanne University Hospital, Rue du Bugnon 23, 1011 Lausanne, Switzerland; Addiction Switzerland, Avenue Louis-Ruchonnet 14, 1003 Lausanne, Switzerland; Centre for Addiction and Mental Health, 1001 Queen Street West, Toronto, ON M6J 1H4, Canada; University of the West of England, Coldharbour Ln, Stoke Gifford, Bristol BS16 1QY, UK.

Patrick Heller (P)

Division of Prison Health, Geneva University Hospitals and University of Geneva, Chemin du Petit Bel Air 2, 1226 Thônex, Switzerland; Adult Psychiatry Division, Department of Mental Health and Psychiatry, Geneva University Hospitals, Chemin du Petit Bel Air 2, 1226 Thônex, Switzerland.

Nader Perroud (N)

Department of Mental Health and Psychiatry, Service of Psychiatric Specialties, University Hospitals of Geneva, Geneva, Switzerland; Department of Psychiatry, University of Geneva, Geneva, Switzerland; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.

Stéphane Rothen (S)

Addiction Division, Geneva University Hospitals and University of Geneva, rue Grand-Pré 70C, 1202 Geneva, Switzerland.

Frank Sporkert (F)

Centre of Legal Medicine, Forensic Toxicology and Chemistry Unit, Lausanne and Geneva Universities, Chemin de la Vulliette 4, 1000 Lausanne, Switzerland.

Joseph Studer (J)

Addiction Medicine, Department of Psychiatry, Lausanne University Hospital, Rue du Bugnon 23, 1011 Lausanne, Switzerland.

Hans Wolff (H)

Division of Prison Health, Geneva University Hospitals and University of Geneva, Chemin du Petit Bel Air 2, 1226 Thônex, Switzerland.

Katia Iglesias (K)

School of Health Sciences, HES-SO University of Applied Sciences and Arts of Western Switzerland, Route des Arsenaux 16a, 1700 Fribourg, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH